Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jazz Pharma Plc (NQ: JAZZ ) 114.29 +0.42 (+0.37%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Jazz Pharma Plc Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders November 14, 2023 From Autifony Therapeutics Ltd Via Business Wire Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030 October 25, 2023 EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END Via FinancialNewsMedia Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty September 22, 2023 FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,... Via FinancialNewsMedia Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation September 20, 2023 Via Investor Brand Network Exposures Product Safety Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation September 20, 2023 EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June May 31, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety The Global Cannabis Pharmaceuticals Market Size Is Expected To Surpass $125 Billion by 2028 April 11, 2023 EQNX::TICKER_START (OTCQX:TCNNF),(OTCQX:CURLF),(NASDAQ:TLRY),(NASDAQ:JAZZ) EQNX::TICKER_END Via FinancialNewsMedia Topics Cannabis Exposures COVID-19 Cannabis Zymeworks Offers Hope for More than Just Long-Term Investors March 09, 2023 Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher Via MarketBeat Struggling Axsome Stock Could Bounce Back on Drug Trial Success November 30, 2022 Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. Via MarketBeat Exposures Product Safety Three CBD Stocks to Dominate a Budding Industry November 23, 2022 The CBD industry is growing at a high 20% CAGR and is expected to more than triple in size over the next 6 to 7 years, that's a budding opportunity. Via MarketBeat Topics Cannabis Exposures Cannabis Product Safety New Drugs in Pipeline for Hypertension, the Silent Global Pandemic August 10, 2022 Via Investor Brand Network Exposures Product Safety New Drugs in Pipeline for Hypertension, the Silent Global Pandemic August 10, 2022 NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill... Via FinancialNewsMedia Exposures Product Safety Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028 May 26, 2022 Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,... Via FinancialNewsMedia Exposures COVID-19 2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO) January 06, 2022 Via AB Newswire Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments August 05, 2021 Via FinancialNewsMedia Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021 June 02, 2021 Via AB Newswire Topics Intellectual Property Exposures Intellectual Property Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels June 08, 2021 Via FinancialNewsMedia Topics Cannabis Economy Exposures COVID-19 Cannabis Economy This Could Be The Most Exciting Healthcare Development Of The Year May 21, 2021 Via FinancialNewsMedia Topics Artificial Intelligence Cannabis Exposures Artificial Intelligence Cannabis PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment April 13, 2021 Via AB Newswire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.